Jean-Emmanuel Rodocanachi

Only 4% of EU VC's have previous startup experience... versus 60% in US  In CVC in EU it will even be worse... (educated guess)  There are some more interesting insights on the low level of support by VC's, the needs from startups, .... in the article below  This confirms also the need for more VC Platform roles in the EU #vcplatform (see my previous post on VC Platform roles)  #venturecapital 

1

2 commentaires

🎥 Last Friday, I had the honor of being invited to the BFM Business morning show to discuss women's cancers and Primaa’s vision for the future of AI in the medical field. Beyond just sharing Primaa’s latest developments, I highlighted our core convictions about how AI can revolutionize healthcare, and particularly pathology: 1️⃣ Relieving overburdened medical services, helping them process more cases with greater speed and efficiency 2️⃣ Reducing inter-observer variability, which can impact patient treatment, ensuring more consistent diagnoses 3️⃣ Disseminating world-class expertise and excellence in care to all regions, ensuring equal access to advanced medical diagnostics 🔴 At a time when budget cuts are being rolled out with the implementation of the new fiscal plan, it's crucial to remember how deeptech startups, especially in the medical field, have thrived thanks to the supportive ecosystem. Some of the proposed measures, such as the elimination of young innovative company (JEI) exemptions and the discontinuation of the innovation tax credit (CII), risk stalling the progress of these crucial innovations... 🔗 Watch the full interview here ➡️: https://lnkd.in/ekAJXjeS #BFMBusiness #Primaa #AI #FannySockeel #WomensHealth #DeepTech #CleoBreast #Pathology #HealthcareInnovation #AIinMedicine #digitalpathology #frenchtech Paul Midy

60

3 commentaires

💡3 debates to keep an eye on for the future of the EU’s Multiannual Financial Framework Last week, I came across the interview of Commissioner for Budget Johannes Hahn in the French newspaper Les Échos. EU correspondent Karl De Meyer captured 3 of the leading budget topics to keep an eye on in the answers of the Commissioner: 1️⃣ New own resources and repayment of the debt In the last MFF negotiations, the idea of creating new resources independent from national contributions had progressed. But despite the efforts of setting some of those resources, such as the flagship Carbon Border Adjustment Mechanism (CBAM, a carbon tax at the EU’s external border), the Council remains somewhat sceptical. As part of the Next Generation EU efforts deployed for the recovery from COVID-19, it was made possible for the Union to borrow €806,9 billion between 2021 and 2026. With repayment starting in 2028, the question is whether new resources will be unlocked on time or whether national contributions will remain the only conceivable option. 2️⃣ Flexibility of the Multiannual Financial Framework As outlined by Commissioner Hahn, 99% of EU resources are pre-allocated within the EU. Consequence: in the last two mandates, we have faced occurrences that made changes vital, whether it is the migration crisis, a global pandemic or a war at our borders - and those changes have been challenging to decide and implement in our institutional scheme. While there are already flexibility instruments in the MFF, i.e., adaptations of headings and programme implementation, the use of margins, a more in-depth reflection will undoubtedly be needed moving on. Otherwise, we will keep displacing capacity from one heading to another, one programme to another, with the risk that policies such as the Cohesion Policy, the Common Agricultural Policy or even the Erasmus programme are first in line to contribute. 3️⃣ Integration of new EU Member States Since December 2022, the question has been on every discussion, at least for those working on agricultural policy: when will new Member States, particularly Ukraine, join the EU - and what will be the consequences for the budget? According to the Commissioner, should the nine current candidate countries enter the EU, our budget would see an increase comprised between 20% and 30%. Making this whole debate about budget, however, would be wrong. Implications of integration have always reached far beyond financial contributions, as the celebration of the 20th EU anniversary of ten of our Member States has shown on 1st May. The interview of Commissioner Hahn is available below. ⤵️

21

1 commentaire

[MEET THE JURY 3] Get ready to meet the exceptional members of our jury! We are delighted to introduce 5 of the investors who will be evaluating the presentations of 20 EIC Fund companies on 13 November at the 𝗘𝗜𝗖 𝗮𝗻𝗱 𝗝&𝗝 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗗𝗮𝘆, 𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝗯𝘆 EuroQuity - Bpifrance. ⭐ Lisanne Blauw Associate at Thuja Capital. Thuja manages several venture capital funds aimed at building and scaling companies in the fields of (bio)pharmaceuticals and medtech. In addition to generating a financial return for investors, Thuja’s investments positively impact the health and well-being of patients. Thuja serves physicians and patients worldwide by providing capital to daring entrepreneurs with ground-breaking product concepts locally.   ⭐ Claire Poulard Investment Director at Turenne Groupe. With more than € 350M dedicated to healthcare, Turenne Capital Healthcare team invests across the whole value chain of healthcare companies in Europe : from venture capital to buy out.   ⭐ Erki Mölder Managing Partner at Verge HealthTech Fund. Verge is an early-stage venture capital firm based in Singapore, exclusively focused on impactful healthcare technologies that have global applicability, especially for underserved populations. The team is composed of former founders or operators who take a hands-on, activist mindset to working with healthtech startups. The partners have invested in over 50 healthtech startups around the world since 2013.   ⭐ Fabienne Roussel, Partner at Vesalius Biocapital IV Partners, which is investing in appealing, later-stage companies in drug development, medical devices & diagnostics and eHealth / mHealth, predominantly in Europe. The companies in their portfolio are dedicated to addressing unmet medical and market needs while prioritizing strong intellectual property protection. Would you like to be part of this ? Make sure to secure your seat. #HealthTech #biotech #medtech #eicAccelerator #EUeic #Healthcare #Investors

36

1 commentaire

Peru’s climate finance moment has arrived. 🇵🇪🌱🌎 The country’s natural resources and biodiversity make it an important destination for capital dedicated to taking care of our planet. The local ecosystem to support entrepreneurs is in place. Various programs are offering investment and value-add support to entrepreneurs. These include: EBBF Amazonia (Kurt Rothschild, Stefanie Delgado), Climate Finance Accelerator (CFA) Libélula (Natalie Rona, Alberto Cuba), NESsT (Diana Alejandra Ramirez, Mauricio Verkooijen), Alianza Empresarial por la Amoniza (Willy Espinoza, Christian Ruiz), Incubagraria , Hub Udep (Carlos Rodrich), among others. Government initiatives from MINAM (Jesus Valverde) and PRODUCE as well was organizations like Profonanpe (Anton Willems, Claudia Godfrey) and Aliados de Impacto-NAB Perú (Marisela Vega) are congregating stakeholders and leading the dialogue for best practicas in impact investing. There is also strong international presence from global NGOs The Nature Conservancy, Conservation International, and WWF Perú. You can see all this activity in a public mapping exercise that highlights many of the key people, organizations, investors, and companies that are part of the climate finance community in Peru. Link to Peru Climate Finance Mapping: https://lnkd.in/exziaZW9 >>>Investors can use the mapping to generate pipeline for future climate finance investments >>>Entrepreneurs can use the mapping to reach out to financing opportunities that match well with their companies The mapping of this dynamic ecosystem in Peru is not complete. We’d love to have your input! If you would like your name or company to be included in the mapping, please fill out the form on the mapping website.

101

4 commentaires